A Validated NMR Approach for MDMA Quantification in Ecstasy Tablets

被引:20
|
作者
Almeida, Nathalia S. [1 ]
Benedito, Luiz E. C. [1 ]
Maldaner, Adriano O. [2 ]
de Oliveira, Aline L. [1 ]
机构
[1] Univ Brasilia, Inst Quim, BR-70910900 Brasilia, DF, Brazil
[2] Policia Fed, Inst Nacl Criminalist, SAIS Quadra 07 Lote 23, BR-70610200 Brasilia, DF, Brazil
关键词
ecstasy; MDMA; qNMR; forensic analysis; validation; SPECTROSCOPY;
D O I
10.21577/0103-5053.20180071
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In recent years, ecstasy trafficking has grown in complexity and tablets has been commonly sold containing different contents of 3,4-methylenedioxymethamphetamine (MDMA) or even other psychoactive substances. In contrast, identification and quantification of drugs of abuse is still a challenge, once the access to drug standards is very restricted in Brazil. In this work, ecstasy tablets seized by the Brazilian Federal Police have their chemical composition identified and quantified by gas chromatography and quantitative H-1 nuclear magnetic resonance based on an internal standard approach (IS-H-1-qNMR). Both methods were validated and showed suitable results for the figures of merit. IS-H-1-qNMR shows excellent results of accuracy (relative error < 5%) and precision (relative standard deviation (RSD) < 2%). Comparatively, IS-H-1-qNMR is more efficient and versatile than gas chromatography to accomplish in a single analysis the identification and quantification of target analytes. Since the method does not require a specific reference material, it is cost effective and provides agility to routine forensic analysis.
引用
收藏
页码:1944 / 1950
页数:7
相关论文
共 50 条
  • [21] Agony and ecstasy: a review of MDMA effects and toxicity
    Burgess, C
    O'Donohoe, A
    Gill, M
    EUROPEAN PSYCHIATRY, 2000, 15 (05) : 287 - 294
  • [22] Chronic MDMA (ecstasy) use, cognition and mood
    K. McCardle
    S. Luebbers
    J. D. Carter
    R. J. Croft
    C. Stough
    Psychopharmacology, 2004, 173 : 434 - 439
  • [23] The neuropsychology of ecstasy (MDMA) use: A quantitative review
    Zakzanis, Konstantine K.
    Campbell, Zachariah
    Jovanovski, Diana
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2007, 22 (07) : 427 - 435
  • [24] Neurotoxicity of Ecstasy (MDMA): An Overview
    Sarkar, Sumit
    Schmued, Larry
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2010, 11 (05) : 460 - 469
  • [25] What's in a Name? Correlates of Ecstasy Users Knowing or Agreeing that Molly is Ecstasy/MDMA
    Palamar, Joseph J.
    JOURNAL OF PSYCHOACTIVE DRUGS, 2018, 50 (01) : 88 - 93
  • [26] Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use
    Gouzoulis-Mayfrank, E
    Fischermann, T
    Rezk, M
    Thimm, B
    Hensen, G
    Daumann, J
    DRUG AND ALCOHOL DEPENDENCE, 2005, 78 (03) : 317 - 323
  • [27] Profiling of Ecstasy Tablets Seized in Iran
    Khajeamiri, Ali Reza
    Kobarfard, Farzad
    Ahmadkhaniha, Reza
    Mostashari, Gelareh
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2011, 10 (02): : 211 - 220
  • [28] Pharmacogenetic studies of change in cortisol on ecstasy (MDMA) consumption
    Wolff, Kim
    Tsapakis, Evangelia M.
    Pariante, Carmine M.
    Kerwin, Robert W.
    Forsling, Mary L.
    Aitchison, Katherine J.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2012, 26 (03) : 419 - 428
  • [29] Development and initial validation of an MDMA/Ecstasy motives assessment
    Sottile, James E.
    Macia, Kathryn S.
    Wickham, Robert E.
    Haug, Nancy A.
    ADDICTIVE BEHAVIORS, 2023, 136
  • [30] Non-linear pharmacokinetics of MDMA ('ecstasy') in humans
    de la Torre, R
    Farré, M
    Ortuño, J
    Mas, M
    Brenneisen, R
    Roset, PN
    Segura, J
    Camí, J
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 49 (02) : 104 - 109